DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)Most-boughtAI cap-ex
TARS
TARSUS PHARMACEUTICALS INC
267 institutions still hold TARSUS PHARMACEUTICALS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 87650L103·Biological Products, (No Diagnostic Substances)·267 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
267 institutions reported TARS in Q1 2026. Deep Track Capital, LP leads at 11.1% of the visible book. +92 net new institutions vs prior quarter — accumulation reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 14
247 more holders available. Log in →